Author

P. Mercer

Observed names: Mercer, P, P Mercer

Observed institutions: University of Siena, Guy's Hospital, Department of Health and Social Care, St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, Public Health England, National Institute for Health and Care Research, University of Bristol, University of Oxford, Azienda Ospedaliera Universitaria Senese

OpenAlex ID: A5109499717

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study

2021 · Victoria Jane Hall, Sarah Foulkes, et al. · The Lancet · 766

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

2021 · Victoria Jane Hall, Sarah Foulkes, et al. · The Lancet · 639

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity

2021 · Chiara Fallerini, Nicola Picchiotti, et al. · Human Genetics · 37

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

Works count: 9

Citation count: 1,539

H-index: 6

I10-index: 6